Clinical Trial Update: Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma [Phase 3]

View source ↗

Summary

A Phase 3 trial assessed the efficacy and safety of fexofenadine for mild-to-moderate persistent asthma. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Allegra (fexofenadine)

Snippet

Sponsor: Sanofi | Conditions: Asthma | Phase 3 | Status: COMPLETED